Cancer biomarkers : section A of Disease markers
May 21, 2025
BackgroundNon-invasive methods with universal prognostic guidance for detecting breast cancer (BC) survival biomarkers need to be further explored.ObjectiveThis study aimed to investigate C-C motif chemokine receptor type 5 (CCR5) prognosis value in ...
OBJECTIVE: To evaluate whether deep learning (DL) analysis of intratumor subregion based on dynamic contrast-enhanced MRI (DCE-MRI) can help predict Ki-67 expression level in breast cancer.
Biomedical physics & engineering express
Feb 25, 2025
Accurate identification of molecular subtypes in breast cancer is critical for personalized treatment. This study introduces a novel neural network model, RAE-Net, based on Multimodal Feature Fusion (MFF) and the Evidential Deep Learning Algorithm (E...
Automated breast tumor segmentation on the basis of dynamic contrast-enhancement magnetic resonance imaging (DCE-MRI) has shown great promise in clinical practice, particularly for identifying the presence of breast disease. However, accurate segment...
AIM: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has proven to be highly sensitive in diagnosing breast tumours, due to the kinetic and volumetric features inherent in it. To utilise the kinetics-related and volume-related informat...
OBJECTIVES: Previous deep learning studies have not explored the synergistic effects of ROI dimensions (2D/2.5D/3D), peritumoral expansion levels (0-8 mm), and segmentation scenarios (ROI only vs. ROI original). Our study aims to evaluate the perform...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.